Medtronic beats quarterly profit estimates on robust demand for heart devices | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A general view of the logo of Medtronic, a healthcare technology and pharmaceutical company, at their plant, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Medtronic Inc]Follow[Abbott Laboratories]Follow[Dexcom Inc]FollowShow more ...

not attempt to provide reconciliations of forward-looking non-GAAP EPS guidance to projected GAAP EPS guidance because the combined impact and timing of recognition of these potential charges or gains is inherently uncertain and difficult to predict and is unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a substantial impact on GAAP measures of financial ...

VB Spine has signed a definitive agreement to acquire Augmedics’ xvision Spine System to add augmented reality (AR) navigation to its enhanced visualisation offerings. The transaction, subject to regulatory approval and customary closing conditions, is anticipated to conclude in the coming weeks. The xvision Spine System integrates navigation benefits with the accessibility of open surgery, allowing direct patient visualisation, workflow efficiency, improved accuracy, and reduced radiation exposure. Ne ...

Market Overview - U.S. stock futures showed fluctuations following a mixed close on Friday, with major indices experiencing weekly losses: S&P 500 down 1.4%, Dow down 1.2%, and Nasdaq down 2.1% [1][2] Index Performance - Dow Jones increased by 0.02%, S&P 500 decreased by 0.14%, Nasdaq 100 fell by 0.47%, and Russell 2000 dropped by 0.21% [3] Stocks in Focus - ZIM Integrated Shipping Services Ltd. surged by 34.46% after agreeing to be acquired by Hapag-Lloyd for $35.00 per share, totaling approximately $4.2 billion [5] - Ocular Therapeutix Inc. rose by 33.56% ahead of announcing topline data for its Phase 3 trial in wet AMD [6] - Toll Brothers Inc. was down by 0.07% with expected earnings of $2.11 per share on revenue of $1.85 billion [7] Analyst Insights - Renowned economist Mohamed El-Erian predicts a "tense tug-of-war" for the U.S. economy in 2026, highlighting a potential decoupling of GDP growth from job creation, which may exacerbate economic inequality [10][11] - El-Erian emphasizes a shift from broad market narratives to a focus on companies effectively integrating AI, indicating that 2026 will require a recalibration of investment strategies [12]

Acquisition Overview - Danaher has agreed to acquire Masimo for $9.9 billion to enhance its diagnostics franchise [1] - The acquisition will allow Masimo to operate as a standalone business unit within Danaher's diagnostics portfolio [1] Strategic Fit - Masimo's advanced sensor technology and AI-enabled monitoring will add significant capabilities to Danaher's diagnostics offerings [2] - The deal, priced at $180 per share, has received unanimous approval from both companies' boards [2] Leadership and Transition - The acquisition follows the resignation of Masimo's CEO Joe Kiani after a conflict with activist investor Politan Capital Management [3] - Katie Szyman, the new CEO of Masimo, believes the partnership with Danaher will enhance the global scalability of Masimo's technologies [3] Value Proposition - Masimo's board evaluated various opportunities and concluded that the transaction with Danaher was the most beneficial for all stakeholders [4] - Masimo is projected to contribute high-single-digit core revenue growth long-term, with expected EBITDA exceeding $530 million by 2027 [5] Timeline and Conditions - The acquisition is expected to close in the second half of 2026, subject to regulatory approvals and other closing conditions [5]

Core Viewpoint - Intuitive Surgical, Inc. (ISRG) is facing challenges in the market despite its strong revenue growth and profitability improvements, with its stock underperforming compared to broader indices over the past year [2][4]. Company Overview - Intuitive Surgical, Inc. is valued at a market cap of $172.5 billion and specializes in robotic-assisted surgical systems and related digital solutions for minimally invasive procedures [1]. Market Performance - Over the past 52 weeks, ISRG shares have declined by 17.9%, while the S&P 500 Index has gained 11.8% [2]. - Year-to-date, ISRG's stock is down 14.2%, contrasting with a slight dip in the S&P 500 [2]. - ISRG has also underperformed compared to the State Street SPDR S&P Health Care Equipment ETF, which saw an 8.3% decline over the past year [3]. Financial Performance - For fiscal Q4 2025, ISRG reported a revenue increase of 19% year-over-year, reaching $2.87 billion, driven by higher procedure volumes and increased placements of da Vinci systems [4]. - Revenue from instruments and accessories rose by 17% to $1.66 billion, with da Vinci procedures growing by 17% and Ion procedures by 44% [4]. - Systems revenue increased to $786 million due to higher placements and average selling prices [4]. - Non-GAAP operating income improved to $1.07 billion, with non-GAAP earnings per share at $2.53, aided by tax benefits [5]. - The company ended the quarter with $9.03 billion in cash, cash equivalents, and investments [5]. Future Outlook - For 2026, Intuitive expects worldwide da Vinci procedure growth of 13% to 15% and a non-GAAP gross margin of 67% to 68% of revenue, factoring in tariff impacts [5]. - Analysts project ISRG's EPS to rise by 13.9% year-over-year to $8.22 for the current fiscal year ending in December [6]. - The company has a strong earnings surprise history, exceeding consensus estimates in each of the last four quarters [6].

Danaher is nearing a roughly $10 billion deal to acquire US medical technology firm Masimo, the Financial Times reports, citing unidentified people familiar with the matter https://t.co/MoQXrdajM1 ...

Group 1 - Danaher is nearing a deal to acquire Masimo for nearly $10 billion, as reported by the Financial Times [1] - Masimo has a market capitalization of approximately $7 billion, indicating a significant premium in the acquisition offer [1] - The announcement of the deal could occur as early as Tuesday, pending any last-minute complications [1]

Market Overview - US stock futures are trending lower, primarily driven by ongoing concerns regarding AI's impact on various industries, leading to a sell-off in tech stocks [1][2] - Nasdaq 100 futures fell by 0.8%, S&P 500 futures decreased by approximately 0.5%, and Dow Jones Industrial Average futures dropped by 0.3% [1] Earnings Reports - The earnings season is nearing its conclusion, with key reports from Constellation Energy, Energy Transfer, Medtronic, and Palo Alto Networks expected this week [3] - Walmart's quarterly report is highly anticipated as it will be the first since the company reached a trillion-dollar market cap [3] Corporate Developments - Paramount Skydance's stock increased by 2% following news that Warner Bros Discovery has requested a better offer from the studio after rejecting its latest bid [4] - Hapag-Lloyd is acquiring ZIM Integrated Shipping Services for $4.2 billion, resulting in a 35% surge in ZIM's shares during premarket trading [11] Investment Activity - DTE Energy's stock rose by 10% before paring gains, with a 13% increase over the past year, as it prepares to release earnings [8] - Norwegian Cruise Line's stock increased by 7% after activist investor Elliott built a stake in the company [8][15] - Masimo's stock surged over 30% following reports of a potential $10 billion acquisition by Danaher [13] Economic Indicators - The upcoming Personal Consumption Expenditures index report is expected to provide insights into consumer inflation trends [5] - An advance look at fourth quarter GDP is scheduled for release, which will contribute to discussions regarding the pace of interest-rate cuts [6]

Core Viewpoint - Avanos Medical, Inc. will host a conference call on February 24, 2026, to discuss its financial results for the fourth quarter and full year 2025, with a news release to be issued prior to market opening on the same day [1] Company Overview - Avanos Medical, Inc. is a medical technology company headquartered in Alpharetta, Georgia, focused on delivering clinically superior medical device solutions to address significant healthcare needs [1] - The company aims to provide essential nutrition to patients transitioning from hospital to home and to reduce opioid use while facilitating recovery from surgery [1] - Avanos develops, manufactures, and markets recognized brands globally, holding leading market positions in multiple product categories [1]